MetaCap

Heartflow (HTFL) vs Stevanato Group S.p.A. (STVN)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Heartflow (HTFL) has outperformed Stevanato Group S.p.A. (STVN) over the past year, gaining 51.3% versus a loss of 30.1%. Stevanato Group S.p.A. is the larger company by market cap ($4.27 billion vs $4.10 billion), about 1.0 times the size. On valuation, Stevanato Group S.p.A. trades at a lower trailing P/E (26.5x vs 69.7x for Heartflow).

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

HTFL+51.35%STVN-30.07%
+103%+28%-48%
Nov 21, 20251 yearNov 20, 2026
HTFL+49.79%STVN-30.81%
+96%+24%-47%
Aug 11, 20255 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

HTFL versus STVN key metrics
MetricHTFLSTVN
Share price$46.69$15.65
Market cap$4.10B$4.27B
1-day change+4.62%-1.76%
YTD return+60.17%-22.22%
1-year return+51.35%-30.07%
5-year return—-30.10%
P/E ratio (TTM)69.6926.53
Forward P/E—21.62
EPS (TTM)$0.67$0.59
Dividend yield0.00%0.39%
Annual dividend$0.00$0.00
Revenue (latest FY)$176.03M—
Revenue growth (YoY)+39.92%—
Net income (latest FY)$-116.79M—
Gross margin76.80%—
Operating margin-36.39%—
Net margin-66.35%—
52-week high$60.66$24.01
52-week low$20.13$12.05
Distance from 52-week high-23.02%-34.82%
Analyst consensusstrong_buybuy
Avg. price target upside+39.22%+24.35%
Average volume1.84M656.22K
Shares outstanding87.89M49.83M
Employees8436,010
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • HTFL has outperformed STVN by 81.4 percentage points over the past year.
  • Heartflow trades at a higher earnings multiple (69.7x vs 26.5x trailing P/E).

About Heartflow

HTFL stock →

HeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases the United States and worldwide. Its HeartFlow Platform uses AI and computational fluid dynamics to creates a personalized 3D model of a patient's heart from a single coronary computed tomography angiography, a specialized type of scan that provides detailed images of the heart's arteries.

Health Care · Medical/Dental Instruments · 843 employees

About Stevanato Group S.p.A.

STVN stock →

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific.

Health Care · Medical/Dental Instruments · 6,010 employees

HTFL vs STVN FAQ

Which is bigger, Heartflow or Stevanato Group S.p.A.?

Stevanato Group S.p.A. (STVN) is larger, with a market capitalization of $4.27B compared with $4.10B for Heartflow (HTFL).

Which stock has performed better over the past year, HTFL or STVN?

HTFL returned +51.35% over the past 12 months, compared with -30.07% for STVN (price return, excluding dividends). Past performance does not predict future results.

Which has the lower P/E ratio, HTFL or STVN?

STVN has the lower trailing P/E at 26.5, versus 69.7 for HTFL. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.

Which pays a higher dividend, Heartflow or Stevanato Group S.p.A.?

Stevanato Group S.p.A. pays a dividend yielding 0.39%, while Heartflow does not currently pay a regular dividend.

Are Heartflow and Stevanato Group S.p.A. in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons